Predictive value of autoantibodies from anti-CCP2, anti-MCV and anti-human citrullinated fibrinogen tests, in early rheumatoid arthritis patients with rapid radiographic progression at 1 year: results from the ESPOIR cohort.

Résumé : We compared the ability of antibodies against cyclic citrullinated peptides (anti-CCP2), against mutated citrullinated vimentin (anti-MCV) and against citrullinated fibrinogen (AhFibA) to predict 1 year rapid radiographic progression (RRP; total Sharp score variation ≥5 points), in early rheumatoid arthritis (RA).
Type de document :
Article dans une revue
RMD Open : Rheumatic & Musculoskeletal Diseases, EULAR ; BMJ, 2015, 1 (1), pp.e000180
Liste complète des métadonnées

http://hal.univ-brest.fr/hal-01559294
Contributeur : Ghislaine Calvez <>
Soumis le : lundi 10 juillet 2017 - 15:35:08
Dernière modification le : mardi 23 janvier 2018 - 11:58:40

Identifiants

  • HAL Id : hal-01559294, version 1
  • PUBMED : 26635969

Citation

Yannick Degboé, Arnaud Constantin, Delphine Nigon, Gabriel Tobon, Martin Cornillet, et al.. Predictive value of autoantibodies from anti-CCP2, anti-MCV and anti-human citrullinated fibrinogen tests, in early rheumatoid arthritis patients with rapid radiographic progression at 1 year: results from the ESPOIR cohort.. RMD Open : Rheumatic & Musculoskeletal Diseases, EULAR ; BMJ, 2015, 1 (1), pp.e000180. 〈hal-01559294〉

Partager

Métriques

Consultations de la notice

65